CF PharmTech, Inc. (HKG:2652)
Hong Kong · Delayed Price · Currency is HKD 34.14
-0.86 (-2.46%)
At close: Dec 30, 2025
CF PharmTech Revenue
CF PharmTech had revenue of 135.94M CNY in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 603.93M. In the year 2024, CF PharmTech had annual revenue of 607.75M with 9.23% growth.
Revenue (ttm)
603.93M CNY
Revenue Growth
+9.23%
P/S Ratio
22.27
Revenue / Employee
1.05M CNY
Employees
574
Market Cap
14.42B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 607.75M | 51.33M | 9.23% |
| Dec 31, 2023 | 556.42M | 207.29M | 59.37% |
| Dec 31, 2022 | 349.13M | 307.14M | 731.54% |
| Dec 31, 2021 | 41.99M | 37.13M | 764.11% |
| Dec 31, 2020 | 4.86M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |